Welcome back to New World next week.

I'm James Corbett, at CorporateReport.com.

And I'm James Evan Palado from Mediamonarchy.com.

That's a bad thing for democracy.

We've got that story plus Patreon imperiled, but first, your medical

martial law updates. We will begin with some of the latest news pretty much all breaking today as we

were taping this. Beginning with Max Blumenthal from the Gray Zone pointing out, Gilead, which

if you don't know that name, you probably should, and if you don't, you probably

will soon. They're going to charge most U.S. patients $3,120 per course, or $520 per vial of the COVID-19

treatment remdesivir. U.S. taxpayers, of course, subsidized much of that drug's development costs.

So which leads to this article from Reuter, state attorneys general urge U.S. to let other firms make

Gilead COVID-19 treatment. A bipartisan group of state attorneys general urged the U.S.

government on Tuesday to allow other companies to make

Gilead Sciences COVID-19 treatment RIMDesivir to increase its availability and lower the price

of the antiviral drug. The coalition of more than 30 state attorneys general called on the

government to act or allow states to do so, saying in a letter to U.S. health agencies that Gilead has not

established a reasonable price for RIMDesivir, Gilead should not profit from the pandemic, and it

should be pushed to do more to help people, the letter said. And of course, remember,

all we've had these stories in the past of jacking up the prices of this medical treatments,

essentially a monopoly. The other scam-demic update coming very recently, red flags soar as

Big Pharma, no surprise. They've had this for somewhat 34 years, I believe, so they're going to

continue to have it moving forward.

...